Home
About
Share This
Set as HomepageFcshp
Professor Neil J MacKinnon, BSc (Pharm), MSc
Journal of Pharmacy Practice and Research Volume 40, No. 3, 2010. 175 Professor Neil J MacKinnon, BSc (Pharm), MSc (Pharm), PhD, FCSHP Editorial Advisory Board Member Journal of Pharmacy Practice and Research, and President Canadian Society of Hospital Pharmacists, and Associate Director for ...
Ruby Grymonpre, PharmD, FCSHP; Cornelia van Ineveld, MD, FRCP ...
Through Teaching Are We Learning? Learning Through Teaching: Facilitating Interprofessional Education Experiences Ruby Grymonpre, PharmD, FCSHP; Cornelia van Ineveld, MD, FRCP(C);
DRUG INTERACTIONS WITH CCR5 ANTAGONISTS Maraviroc, MVC ...
Academic copyright. Alice Tseng, Pharm.D.FCSHP, Toronto General Hospital, Toronto, ON www.hivclinic.ca July 19, 2011 Page 1 of 15 DRUG INTERACTIONS WITH CCR5 ANTAGONISTS
A New Challenge for You Bonnie Kirschenbaum, MS, FASHP, FCSHP
White Bagging……. A New Challenge for You Bonnie Kirschenbaum, MS, FASHP, FCSHP . Breckenridge, Colorado bkirschen@aol.com
decreasing demand by increasing evidence-based knowledge ...
... FCSHP Executive Director, Drug Use Optimization Branch Pharmaceutical Services Division BC Ministry of Health 2011 CADTH Symposium 4Apr2011.
ByChristineKoczmara,RN,BSc, LarryBroadfield,BScPhm,MHSc,FCSHP ...
Anearmissinvolving cyclophosphamide ByChristineKoczmara,RN,BSc, LarryBroadfield,BScPhm,MHSc,FCSHP, SylviaHyland,BScPhm,MHSc(Bioethics),and RogerCheng,RPh,BScPhm,PharmD
Book 1 Table of Contents
... DATA IN CARDIOVASCULAR DISEASE CLINICAL TRIALS: A BIOSTATISTICAL TOOLBOx By Ross T. Tsuyuki, BSPharm, Pharm.D., M.Sc., FCSHP, FACC; and Sipi Garg, ...
Improving IV Medication Safety: Identifying the Risk Points
Improving IV Medication Safety: Identifying the Risk Points A G E N D A 11:30 a.m. - 11:35 a.m. Welcome / Introductory Remarks Rita Shane, Pharm.D., FASHP, FCSHP Program Chair 11:35 a.m. - 12:10 p.m. Identifying the Risk Points: Back to the Basics Rita Shane, Pharm.D., FASHP, FCSHP 12:10 p.m ...
Type 2 Diabetes and Cardiovascular Disease:
Table of Contents Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk S2 Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk David W. Bartels, PharmD, BCPS, CDE, FCCP; Michael H. Davidson, MD, FACC, FACP; and William C. Gong, PharmD, FASHP, FCSHP S16 Continuing Education*: CE ...
Ulcers & GI Bleeds: As the Stomach Turns
Peter Loewen, PharmD, FCSHP 1MAY04 5 Ulcer/Bleed on NSAID? Omeprazole 20 or 40mg/d superior to placebo, ranitidine, and misoprostol 200 qid for preventing recurrent endoscopic lesions @ 6mos in NSAID users [ASTRONAUT, OMNIUM] In H.pylori(+) patients, eradication inferior to omeprazole ...
